In Silico Drug Repurposing of FDA-Approved Drugs Highlighting Promacta as a Potential Inhibitor of H7N9 Influenza Virus

Influenza virus infections continue to be a significant and recurrent public health problem. Although vaccine efficacy varies, regular immunisation is the most effective method for suppressing the influenza virus. Antiviral drugs are available for influenza, although two of the four FDA-approved ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Mtambo, Sphamandla E., Kumalo, Hezekiel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321947/
https://www.ncbi.nlm.nih.gov/pubmed/35889388
http://dx.doi.org/10.3390/molecules27144515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321947/
https://www.ncbi.nlm.nih.gov/pubmed/35889388
http://dx.doi.org/10.3390/molecules27144515

Ejemplares similares